US Patent

US8501818 — Stabilized compositions of alkylating agents and methods of using same

Formulation · Assigned to Ceptaris Therapeutics Inc · Expires 2026-03-07 · 0y expired

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

Ceptaris Therapeutics Inc. has patented stable compositions of alkylating agents, including nitrogen mustards, for topical use in treating skin disorders.

USPTO Abstract

Provided are stable compositions comprising alkylating agents, including nitrogen mustards, that are suitable for topical use, and methods for treating skin disorders comprising topically administering the compositions.

Drugs covered by this patent

mechlorethamine-hydrochloride (MECHLORETHAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: US8501818
Jurisdiction: US
Classification: Formulation
Expires: 2026-03-07
Drug substance claim: No
Drug product claim: Yes
Assignee: Ceptaris Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.